Growth and differentiation of keratinocytes : Molecular and histological study
Growth and differentiation of keratinocytes : Molecular and histological study
批准号:
07807168
负责人:
HARADA Hidemitsu
金额:
$1.34万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 1996
中文摘要
口腔角质形成细胞起源于基底细胞,在迁移到表面的过程中分化,最后脱落。细胞凋亡发生在分化末期,但分化末期与细胞凋亡之间的确切关系尚不清楚。在目前的研究中,bcl-2原癌基因是一种已知的细胞凋亡抑制剂;在正常人的层状鳞状上皮中,其表达仅限于基底细胞层。Bcl-xL表达于基底细胞层和棘细胞层,Bax表达于棘细胞层和颗粒细胞层。在培养的角化细胞中,Bcl-xL在0.1 mM钙(低Ca2+)条件下表达,但在1.0 mM钙(高Ca2+)条件下消失;后者诱导角质细胞分化。Bax在低Ca2+的角质形成细胞中不表达,但在高Ca2+的细胞中表达。最后,高Ca2+的角化细胞凋亡,通过TUNEL法和180 bp DNA片段检测。为了研究bcl-2蛋白在口腔角质形成细胞分化过程中的功能作用,我们将bcl-2表达载体转染到SCC-25细胞中,SCC-25细胞在体外正常进行鳞状细胞分化,同时表达特异性分化标志物,如角质蛋白10/11和天花素。在bcl-2转染的SCC-25细胞中,这些分化标志物的表达明显受到抑制。bcl-2原癌基因可能在反对口腔角化细胞向终末分化和凋亡的承诺中起关键作用。提示牙龈上皮终末分化过程是细胞凋亡的一个途径。
英文摘要
Oral keratinocytes originate from basal cells, differentiate during migration to the surface, and finally are shed. Apoptosis occurs at the end of differentiation, but the precise relationship between terminal differentiation and apoptosis is not clear. In the present study, The bcl-2 proto-oncogene is a known inhibitor of apoptosis ; in normal human stratified squamous epithelium its expression is restricted to the basal cell layr. Bcl-xL was expressed in the basal cell and spinous cell layrs, and Bax was expressed in the spinous cell and granular cell layrs. In cultured keratinocytes, Bcl-xL was expressed under conditions of 0.1 mM calcium (low Ca2+) but disappeared under conditions of 1.0 mM calcium (high Ca2+) ; the latter induces keratinocyte differentiation. Bax was not expressed in keratinocytes with low Ca2+ but was expressed in cells with high Ca2+. And finally keratinocytes with high Ca2+ underwent apoptosis, which was detected by the TUNEL method and by 180-bp DNA fragmentation. To investigate the functional role of bcl-2 protein in the process of differentiation of oral keratinocytes, bcl-2 expression vector was transfected into SCC-25 cells, which normally undergo squamous cell differentiation in vitro while expressing specific differentiation markers, e.g., keratin10/11 and involucrin. In bcl-2 transfected SCC-25 cells, the expression of these differentiation markers was markedly suppressed.The bcl-2 proto-oncogene may play a critical role in opposing the commitment to terminal differentiation and apoptosis of oral keratinocytes. These results suggest that the process of terminal differentiation in gingival epithelium is a pathway to apoptosis.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Hidemitsu Harada, et al.: "Overexpression of bcl-2 protein inhibits terminal differentiation of oral keratinocytes in vitro." Journal of oral pathology & Medicine. 27. 11-18 (1998)
Hidemitsu Harada 等人:“bcl-2 蛋白的过度表达可抑制体外口腔角质形成细胞的终末分化。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hidemitsu Harada, Takeshi Mitsuyasu, Yuji Seta, Yuka Maruoka, Kuniaki Toyoshima, Shigeru Yasumoto: "Overexpression of bcl-2 protein inhibits terminal differentiation of oral keratinocytes in vitro." J.Oral Pathol.Med.27. 11-17 (1998)
Hidemitsu Harada、Takeshi Mitsuyasu、Yuji Seta、Yuka Maruoka、Kuniaki Toyoshima、Shigeru Yasumoto:“bcl-2 蛋白的过度表达在体外抑制口腔角质形成细胞的终末分化。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yuka Maruoka, Hidemitsu Harada et al.: "Keratinocytes become terminally differentiated in a process involving programmed cell death" Biochemical and Biophysical Research Communications. 238. 886-890 (1997)
Yuka Maruoka、Hidemitsu Harada 等人:“角质形成细胞在涉及程序性细胞死亡的过程中最终分化”生物化学和生物物理研究通讯。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yuka Maruoka, Hidemitsu Harada, Takeshi Mitsuyasu, Yuji Seta, Hideo Kurokawa, Minoru Kajiyama, Kuniaki Toyoshima: "Keratinocytes become terminally differentiated in a process involving programd cell death." Biochem.Biophys.Res.Commun.238. 886-890 (1997)
Yuka Maruoka、Hidemitsu Harada、Takeshi Mitsuyasu、Yuji Seta、Hideo Kurokawa、Minoru Kajiyama、Kuniaki Toyoshima:“角质形成细胞在涉及程序性细胞死亡的过程中发生终末分化。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Is epithelial-mesenchymal transition of stellate reticulum cells in enamel organ associated with induction of vasculogenesis?
-
批准号:24659818
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2012
-
负责人:HARADA Hidemitsu
-
依托单位:
Study on mechanisms of odontoblasts processes formation and dentin development
-
批准号:19390466
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.56万
-
财政年份:2007
-
负责人:HARADA Hidemitsu
-
依托单位:
Regeneration of tooth germ using dental epithelial stem cells and dental papilla mesenchymal stem cells in rodent incisors
-
批准号:16390527
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.7万
-
财政年份:2004
-
负责人:HARADA Hidemitsu
-
依托单位:
Elucidation of molecular mechanisms on transition from crown to root in tooth development
-
批准号:13470387
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$3.2万
-
财政年份:2001
-
负责人:HARADA Hidemitsu
-
依托单位:
国内基金
海外基金
登录
查看更多内容
针刺强度通过调控Beclin-1/LC3与Bcl-2/Bax平衡促进面神经修复的量效机制研究
-
批准号:2026JJ82043
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:张珂胜
-
依托单位:
非小细胞肺癌光诊疗中靶向Bcl-2新型PROTAC荧光探针的构建与评价
-
批准号:QN25H300004
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:胡壮
-
依托单位:
SENP1介导急性髓系白血病对BCL-2抑制剂耐药的机制研究
-
批准号:2025JJ50476
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:张简
-
依托单位:
黄芩苷上调Bcl-XL/Bcl-2通过Nrf2-GPX4通路抑制铁死亡减轻大鼠肠道缺血再灌注损伤
-
批准号:2025JJ81028
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:翟溶凡
-
依托单位:
靶向 MLL-Menin 和 BCL-2 协同抑制 TIFAB 进
而平衡经典和非经典 NF-κB 通路治疗
MLLr-AML
-
批准号:Q24H080020
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:凌清
-
依托单位:
Bcl-2原位成像的 AIE 呫吨酮碳苷分子探针挖掘及肿瘤早
期诊断研究
-
批准号:2024JJ8119
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:施树云
-
依托单位:
Bcl-2通过 p21 及 p53 通路调控细胞增殖与凋亡参与动脉粥样硬化的机制研究
-
批准号:2024JJ7350
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:江涛
-
依托单位:
HMGA2调节DNA甲基化水平介导BCL-2上调促进肺癌对奥希替尼耐
药的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:戴富强
-
依托单位:
NSUN4通过抑制p53信号通路在弥漫大B细胞淋巴瘤BCL-2抑制剂耐药中的作用及分子机制研究
-
批准号:82300213
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:史远飞
-
依托单位:
CXCL1/CXCR2信号轴上调Bcl-2促进筋膜定植巨噬细胞迁移在皮下脂肪组织原位再生中的机制研究
-
批准号:82360615
-
项目类别:地区科学基金项目
-
资助金额:32万元
-
批准年份:2023
-
负责人:毕鑫
-
依托单位: